Skip to main content

Ikarian Capital, LLC

SEC CIK
0001778253
Latest filing
Aug 14, 2026

NKTR holding history

Nektar Therapeutics in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NKTR overviewAll 13F holders of NKTRFull Q2 2026 holdings

Shares (Q2 2025)
0
Sold out in Q2 2025
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q2 2024
Holdings of NKTR by Ikarian Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20250$00.0%−105,302−100.0%Sold outConverted for a 1-for-15 splitHolders
Q1 20251,579,528$1.07M0.3%−449,500−22.2%ReducedHolders
Q4 20242,029,028$1.89M0.5%+716,623+54.6%AddedHolders
Q3 20241,312,405$1.71M0.5%00.0%UnchangedHolders
Q2 20241,312,405$1.63M0.5%+1,312,405NewHolders